Abstract:
Objective This study aims to analyze the miR-25 expression profile in gastric cancer(GC) tissue and identify its novel target gene.
Methods Ten paired GC tissues and adjacent normal tissues were included in this study.MiR-25 expression levels were measured via quantitative reverse transcription polymerase chain reaction(qRT-PCR).The target genes of the miR-25 were predicted in the miRNA Target Database.Luciferase(pMIR-TOB1) and GFP reporters(pMIR-GFP-TOB1), which contain the binding site of miR-25 to TOB1 3'UTR, were constructed.The predicted target gene(TOB1) of miR-25 was identified via luciferase activation and GFP expression assays.The mRNA or protein expression of TOB1 was detected via qRT-PCR or Western blot, respectively.
Results Increased expression of miR-25 was observed in eight GC tissues(80%).miR-25 mimics significantly inhibited luciferase activation(P < 0.01) and GFP expression in the HEK293 cells, and significantly decreased the mRNA(P < 0.05) and protein expression levels of TOB1 in the AGS cells.
Conclusion miR-25 is significantly increased in human GC tissue.Moreover, MiR-25 can significantly repress the mRNA and protein expression of TOB1 by directly targeting 3'UTR.